Evidence map›Paper›PMID 34159400›Full record

ArticleHuman genetics2021

Genome sequencing in families with congenital limb malformations.

Jonas Elsner, Martin A Mensah, Manuel Holtgrewe, Jakob Hertzberg, Stefania Bigoni, Andreas Busche, Marie Coutelier, Deepthi C de Silva, Nursel Elçioglu, Isabel Filges and 22 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The RSPO2 gene is associated with bilateral anterior amelia in Chihuahuas.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 13 countries.

Jonas Elsner *Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Martin A Mensah *Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Manuel HoltgreweCore Unit Bioinformatics, Berlin Institute of Health (BIH), Berlin, Germany.
Jakob HertzbergMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany.
Stefania BigoniMedical Genetics Unit, Department of Mother and Child, Ferrara Sant'Anna University Hospital, Ferrara, Italy.
Andreas BuscheInstitut Für Humangenetik, Universitätsklinikum Münster, Münster, Germany.
Marie CoutelierInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Deepthi C de SilvaFaculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Nursel ElçiogluDepartment of Pediatric Genetics, Marmara University Medical School, Istanbul, Turkey.
Isabel FilgesInstitut für Medizinische Genetik und Pathologie, Universitätsspital Basel, Basel, Switzerland.
Erica GerkesDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Katta M GirishaDepartment of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Luitgard Graul-NeumannInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Aleksander JamsheerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Peter KrawitzInstitute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany.
Ingo KurthInstitute of Human Genetics, Medical Faculty, RWTH Aachen University Hospital, Aachen, Germany.
Susanne MarkusFachärztin Für Humangenetik, Bischof-von-Henle-Straße 2a, Regensburg, Germany.
Andre MegarbaneDepartment of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
André ReisInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Miriam S ReuterInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Daniel SvobodaKinderhandchirurgie, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany.
Christopher TellerSynlab MVZ Bad Nauheim, Mondorfstr. 1761231, Bad Nauheim, Germany.
Beyhan TuysuzDepartment of Pediatric Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Seval TürkmenInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Meredith WilsonGenetic Medicine, Children's Hospital at Westmead, Paediatrics and Child Health, Sydney, Australia.
Rixa WoitschachInstitute of Human Genetics, University Medical Center Hamburg, Eppendorf, Germany.
Inga VaterInstitute of Human Genetics, University of Kiel, Kiel, Germany.
Almuth CaliebeInstitute of Human Genetics, University of Kiel, Kiel, Germany.
Wiebke HülsemannKatholisches Kinderkrankenhaus Wilhelmstift, Hamburg, Germany.
Denise HornInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Stefan Mundlos *Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. stefan.mundlos@charite.de.
Malte Spielmann *Max Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany. malte.spielmann@uksh.de.
Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEKiel University · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEMax Planck Institute for Molecular Genetics · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEChildren's Hospital at Westmead · AUEastern Mediterranean University · CYHeidelberg University · DEIstanbul University-Cerrahpaşa · TRKasturba Medical College, Manipal · INKatholisches Kinderkrankenhaus Wilhelmstift · DEKlinik und Poliklinik für Psychosomatik und Psychotherapie · DELebanese American University · LBPoznan University of Medical Sciences · PLPraxis für Humangenetik · DESynlab (Germany) · DEUniversitätsklinikum Aachen · DEUniversity Hospital of Basel · CHUniversity Medical Center Hamburg-Eppendorf · DE

Funding

Deutsche Forschungsgemeinschaft SP1532/3-1Deutsche Forschungsgemeinschaft SP1532/4-1Deutsche Forschungsgemeinschaft SP1532/5-1Deutsches Zentrum für Luft- und Raumfahrt DLR 01GM1925Polish National Science Center (PL) UMO-2016/22/E/NZ5/00270
6 · The paper itself

Abstract

The extensive clinical and genetic heterogeneity of congenital limb malformation calls for comprehensive genome-wide analysis of genetic variation. Genome sequencing (GS) has the potential to identify all genetic variants. Here we aim to determine the diagnostic potential of GS as a comprehensive one-test-for-all strategy in a cohort of undiagnosed patients with congenital limb malformations. We collected 69 cases (64 trios, 1 duo, 5 singletons) with congenital limb malformations with no molecular diagnosis after standard clinical genetic testing and performed genome sequencing. We also developed a framework to identify potential noncoding pathogenic variants. We identified likely pathogenic/disease-associated variants in 12 cases (17.4%) including four in known disease genes, and one repeat expansion in HOXD13. In three unrelated cases with ectrodactyly, we identified likely pathogenic variants in UBA2, establishing it as a novel disease gene. In addition, we found two complex structural variants (3%). We also identified likely causative variants in three novel high confidence candidate genes. We were not able to identify any noncoding variants. GS is a powerful strategy to identify all types of genomic variants associated with congenital limb malformation, including repeat expansions and complex structural variants missed by standard diagnostic approaches. In this cohort, no causative noncoding SNVs could be identified.

Indexed as

Genetic HeterogeneityMutationBase SequenceCohort StudiesDNA Copy Number VariationsGene ExpressionGenetic TestingHomeodomain ProteinsHumansInfantLimb Deformities, CongenitalMalePedigreeTranscription FactorsUbiquitin-Activating EnzymesWhole Genome SequencingHomeodomain ProteinsHOXD13 protein, humanTranscription FactorsUBA2 protein, humanUbiquitin-Activating Enzymes

Identifiers

PMID34159400
PMCPMC8263393
OpenAlexW3174225257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.